Pathstone Holdings’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.01M Buy
15,086
+3,783
+33% +$1.08M 0.02% 576
2026
Q1
$1.96M Sell
11,303
-1,501
-12% -$308K 0.01% 1039
2025
Q4
$3.28M Sell
12,804
-738
-5% -$193K 0.01% 760
2025
Q3
$3.53M Buy
13,542
+1,706
+14% +$449K 0.01% 708
2025
Q2
$2.9M Sell
11,836
-1,698
-13% -$423K 0.01% 785
2025
Q1
$3.59M Sell
13,534
-107
-0.8% -$28.9K 0.02% 683
2024
Q4
$3.47M Sell
13,641
-2,967
-18% -$796K 0.02% 694
2024
Q3
$5.27M Sell
16,608
-1,727
-9% -$615K 0.02% 527
2024
Q2
$6.86M Buy
18,335
+2,970
+19% +$1M 0.03% 427
2024
Q1
$5.33M Buy
15,365
+1,116
+8% +$423K 0.02% 487
2023
Q4
$6.53M Buy
+14,249
New +$7.02M 0.04% 364

Other funds holding HUM

Pathstone Holdings's HUM Position: Q2 2026 in Review

Pathstone Holdings increased its Humana (HUM) stake by 33% in Q2 2026, buying an estimated $1.08M and bringing the position to 15,086 shares worth $6.01M. The position accounts for 0.02% of the portfolio, ranked #576.

Pathstone Holdings first reported a position in HUM in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.86M in Q2 2024. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Pathstone Holdings held 15,086 shares of Humana worth $6.01M as of Q2 2026.
  • Pathstone Holdings bought 3,783 Humana shares in Q2 2026, an estimated $1.08M.
  • Humana made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #576 holding.
  • Pathstone Holdings first reported a position in Humana in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Humana position peaked at $6.86M in Q2 2024.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.